Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net loss	$ (3,701,297)	$ (6,051,127)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	28,587	28,014
Stock based compensation	152,133	338,580
Fair market value of common stock, warrants and options issued for services	0	225,158
Loss on extension of warrants	0	143,363
Loss on debt conversion	0	2,754,062
Amortization of debt discount and deferred financing costs	360,636	131,074
Changes in operating assets and liabilities:
Accounts receivable	191,673	79,951
Prepaid expenses and other current assets	(109,149)	4,396
Accounts payable and other current liabilities	(133,730)	(776,559)
Due to related parties	9,000	(28,689)
Net cash used in operating activities	(3,202,147)	(3,151,777)
Cash flows from investing activities:
Purchases of office equipment	(9,307)	0
Net cash used in investing activities	(9,307)	0
Cash flows from financing activities:
Proceeds from the issuance of notes payable	0	415,000
Principal repayments of notes payable	0	(500,920)
Proceeds from the issuance of common stock, net	5,606,755	4,763,153
Cash at beginning of period	855,596	1,250,279
Cash at end of period	3,250,897	2,775,735
Cash paid during the period for:
Interest	0	435,139
Supplemental disclosures of non-cash investing and financing activities:
Debt and accrued interest converted to common stock	0	2,065,787
Reclassification of warrant derivative liability into equity	0	10,679,067
Deferred financing costs recorded	0	117,280
Reclassification of accrued interest to convertible notes payable	0	25,766
Debt discount related to warrants and beneficial conversion feature	0	527,780
Cashless exercise of warrants	$ 5	$ 21,516